Servicio Andaluz De Salud

Fundacion Publica Andaluza Progreso Y Salud

Carmen Cepeda Franco

Rafael Campos Cuerva

Beatriz Fernandez Muñoz

Miguel Angel Gómez Bravo

Jordi Muntane Relat

Beatriz Fernandez MUÑOZ

Miguel Angel GÓMEZ Bravo

The present invention provides for nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (NFAH) or non-nanostructured or pre-nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (FAH), as hemostatic agents designed for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and in trauma. These hydrogels can be applied topically to the wound either on the skin in a laparotomy or as non-invasive manner in surgical procedures. Its nanostructure technology generates an adhesive stable fibrin clot required for hemostasis. The attachment properties of the hydrogel, as well as the rapid formation of a fibrin clot, ensures that a strong stable fibrin clot is formed shortly after application.

Hemostatic efficacy of a nanostructured fibrin agarose hydrogel

Growing community of inventors

Seville, Spain

Carmen Cepeda Franco